Literature DB >> 24206456

The end of dual therapy with renin-angiotensin-aldosterone system blockade?

Dick de Zeeuw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24206456     DOI： 10.1056/NEJMe1312286

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.

Authors:  Francesca Viazzi; Barbara Bonino; Francesca Cappadona; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2016-03-17       Impact factor: 3.397

2.  Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project).

Authors:  Anna M Maw; Lauren E Thompson; P Michael Ho; Kevin F Kennedy; Thomas M Maddox; Javier A Valle; Amneet Sandhu; Frederick A Masoudi; Franz H Messerli; Stacie L Daugherty
Journal:  Am J Cardiol       Date:  2019-10-11       Impact factor: 2.778

3.  Heart failure: New data do not SUPPORT triple RAAS blockade.

Authors:  A H Jan Danser; Anton H van den Meiracker
Journal:  Nat Rev Nephrol       Date:  2015-03-24       Impact factor: 28.314

Review 4.  Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.

Authors:  Raquel Esteras; Maria Vanessa Perez-Gomez; Laura Rodriguez-Osorio; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Ther Adv Drug Saf       Date:  2015-08

5.  The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Ya Luo; Kai Lu; Gang Liu; Jing Wang; Irakoze Laurent; Xiaoli Zhou
Journal:  Clin Drug Investig       Date:  2018-12       Impact factor: 2.859

6.  How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.

Authors:  Alfred Penfornis; Jean Frédéric Blicklé; Béatrice Fiquet; Stéphane Quéré; Sylvie Dejager
Journal:  Vasc Health Risk Manag       Date:  2014-06-13

7.  Albumin-induced apoptosis of tubular cells is modulated by BASP1.

Authors:  M D Sanchez-Niño; B Fernandez-Fernandez; M V Perez-Gomez; J Poveda; A B Sanz; P Cannata-Ortiz; M Ruiz-Ortega; J Egido; R Selgas; A Ortiz
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

8.  Renal kallikrein activation and renoprotection after dual blockade of renin-angiotensin system in diet-induced diabetic nephropathy.

Authors:  Xia Zou; Xiao-xi Zhang; Xin-yu Liu; Rong Li; Min Wang; Wei-jie Wu; Yi Sui; Hai-lu Zhao
Journal:  J Diabetes Res       Date:  2015-03-30       Impact factor: 4.011

Review 9.  Treatment strategies to prevent renal damage in hypertensive children.

Authors:  Piotr Czarniak; Aleksandra Zurowska
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.